Maximum Effect of Urokinase Plasminogen Activator Inhibitors in the Control of Invasion and Metastasis of Rat Mammary Cancer

1998 ◽  
Vol 18 (5-6) ◽  
pp. 252-260 ◽  
Author(s):  
Douglas M. Evans ◽  
Kimberly D. Sloan-Stakleff
Keyword(s):  
Plasminogen Activator ◽  
Mammary Cancer ◽  
Urokinase Plasminogen Activator ◽  
Maximum Effect ◽  
Invasion And Metastasis ◽  
Plasminogen Activator Inhibitors

Structure-Based design, synthesis and sAR of a novel series of thiopheneamidine urokinase plasminogen activator inhibitors

2001 ◽  
Vol 11 (11) ◽  
pp. 1379-1382 ◽  
Author(s):  
Nalin L. Subasinghe ◽  
Carl Illig ◽  
James Hoffman ◽  
M.Jonathan Rudolph ◽  
Kenneth J. Wilson ◽  
...  
Keyword(s):  
Plasminogen Activator ◽  
Urokinase Plasminogen Activator ◽  
Plasminogen Activator Inhibitors ◽  
Design Synthesis

Naphthamidine urokinase plasminogen activator inhibitors with improved pharmacokinetic properties

2005 ◽  
Vol 15 (1) ◽  
pp. 93-98 ◽  
Author(s):  
Milan Bruncko ◽  
William J. McClellan ◽  
Michael D. Wendt ◽  
Daryl R. Sauer ◽  
Andrew Geyer ◽  
...  
Keyword(s):  
Plasminogen Activator ◽  
Urokinase Plasminogen Activator ◽  
Plasminogen Activator Inhibitors ◽  
Pharmacokinetic Properties

Expression of plasminogen activator inhibitors type 1 and type 3 and urokinase plasminogen activator protein and mRNA in breast cancer

2007 ◽  
Vol 120 (5) ◽  
pp. 753-762 ◽  
Author(s):  
Remedios Castelló ◽  
Jose M. Landete ◽  
Francisco España ◽  
Carlos Vázquez ◽  
Carlos Fuster ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Plasminogen Activator ◽  
Urokinase Plasminogen Activator ◽  
Plasminogen Activator Inhibitors ◽  
Activator Protein ◽  
Type 3
Sign in / Sign up

Export Citation Format

Share Document